<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-O32GSUY9</identifier><date>2006</date><creator>Frlan, Rok</creator><creator>Sollner Dolenc, Marija</creator><relation>documents/znanstveni_clanki/farmacevtski_vestnik/html/urn_nbn_si_doc-o32gsuy9.html</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/pdf/urn_nbn_si_doc-o32gsuy9.pdf</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/txt/urn_nbn_si_doc-o32gsuy9.txt</relation><format format_type="issue">2</format><format format_type="volume">57</format><format format_type="main">6 strani</format><format format_type="type">article</format><format format_type="extent">str. 140-145</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">1963121</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-O32GSUY9</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">citokromi</subject><subject language_type_id="slv">inhibicija</subject><subject language_type_id="slv">inhibitorji</subject><subject language_type_id="slv">kataliza</subject><subject language_type_id="slv">modulatorji</subject><subject language_type_id="slv">naravne snovi</subject><title>Inhibitorji citokromov</title></Record>